Alzamend Neuro Inc expected to post a loss of $2.75 a share - Earnings Preview

Alzamend Neuro

25/07/2024 21:53

* Alzamend Neuro Inc  ALZN.OQ   ALZN.O  is expected to show
no
change in quarterly revenue when it reports  results on July 27
(estimated) for the period ending April 30 2024
    * 
    * ​LSEG's mean analyst estimate for Alzamend Neuro Inc is
for a
loss of $2.75 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alzamend
Neuro
Inc is $210.00​, above​ its last closing price of $3.64. ​​​

This summary was machine generated July 25 at 20:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)